Roberto Pedro Rosenkranz is Director at FIBROGEN INC (FGEN). They have made 8 open-market trades across 1 company since 2018, most recently 2020-06-09.
CIK 0001621332
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 8 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| FGEN | 96,100 | $933K |
Shares reported on the most recent Form 4, priced at the 2020-06-11 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| FGEN | SELL · 10b5-1 | 2018-12-20 | 2018-12-21 | $41.00 | $41K | +13.9% | +29.1% | +39.6% |
| FGEN | SELL · 10b5-1 | 2018-11-15 | 2018-11-16 | $39.24 | $39K | +4.8% | -3.3% | +41.3% |
| FGEN | SELL | 2018-10-18 | 2018-10-19 | $55.44 | $107K | -19.0% | -25.9% | -4.0% |
| FGEN | SELL | 2018-09-20 | 2018-09-21 | $56.95 | $57K | +3.9% | -12.6% | -26.7% |
| FGEN | SELL · 10b5-1 | 2018-08-16 | 2018-08-17 | $60.28 | $60K | -0.5% | -7.2% | -34.1% |
| FGEN | SELL | 2018-07-19 | 2018-07-20 | $64.90 | $130K | -2.4% | -8.9% | -16.1% |
| FGEN | SELL | 2018-06-21 | 2018-06-22 | $63.65 | $64K | -2.1% | +2.5% | -9.0% |
| FGEN | SELL | 2018-05-17 | 2018-05-18 | $52.20 | $52K | +5.2% | +16.5% | +18.1% |
| FGEN | SELL · 10b5-1 | 2018-04-19 | 2018-04-20 | $47.70 | $48K | +1.2% | +12.8% | +38.2% |
| FGEN | SELL · 10b5-1 | 2018-03-15 | 2018-03-16 | $52.34 | $52K | -10.0% | -7.3% | +15.5% |
| FGEN | SELL · 10b5-1 | 2018-02-15 | 2018-02-16 | $55.90 | $56K | -1.8% | -10.5% | -8.3% |
| FGEN | SELL | 2018-01-26 | 2018-01-30 | $60.00 | $360K | -16.3% | -9.2% | -24.9% |
| FGEN | SELL | 2018-01-22 | 2018-01-24 | $50.00 | $100K | +0.0% | +8.1% | -11.9% |
| FGEN | SELL | 2018-01-18 | 2018-01-19 | $47.45 | $285K | +21.1% | +12.9% | -3.6% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.